Full text

Turn on search term navigation

© 2022 Castrosanto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The brown dog tick (Rhipicephalus sanguineus) is the most prevalent tick in the world and a well-recognized vector of many pathogens affecting dogs and occasionally humans. Pathogens exploit tick salivary molecules for their survival and multiplication in the vector and transmission to and establishment in the hosts. Tick saliva contains various non-proteinaceous substances and secreted proteins that are differentially produced during feeding and comprise of inhibitors of blood congealing and platelet aggregation, vasodilatory and immunomodulatory substances, and compounds preventing itch and pain. One of these proteins is Evasin-1, which has a high binding affinity to certain types of chemokines. The binding of Evasin-1 to chemokines prevents the detection and immune response of the host to R. sanguineus, which may result in the successful transmission of pathogens. In this study, we screened potential Evasin-1 inhibitor based on the pharmacophore model derived from the binding site residues. Hit ligands were further screened via molecular docking and virtual ADMET prediction, which resulted in ZINC8856727 as the top ligand (binding affinity: -9.1 kcal/mol). Molecular dynamics simulation studies, coupled with MM-GBSA calculations and principal component analysis revealed that ZINC8856727 plays a vital role in the stability of Evasin-1. We recommend continuing the study by developing a formulation that serves as a potential medicine aid immune response during R. sanguineus infestation.

Details

Title
Abetting host immune response by inhibiting rhipicephalus sanguineus Evasin-1: An in silico approach
Author
Castrosanto, Melvin A  VIAFID ORCID Logo  ; Mukerjee, Nobendu; Contributed equally to this work with: Nobendu Mukerjee; Maitra, Swastika; Das, Padmashree  VIAFID ORCID Logo  ; Padmashree Das John Julius P. Manuben  VIAFID ORCID Logo  ; Padmashree Das Sumira Malik  VIAFID ORCID Logo  ; Hasan, Mohammad Mehedi; Alexiou, Athanasios; Dey, Abhijit; Mohammad Amjad Kamal; Aljarba, Nada H  VIAFID ORCID Logo  ; Alkahtani, Saad; Ghosh, Arabinda  VIAFID ORCID Logo 
First page
e0271401
Section
Research Article
Publication year
2022
Publication date
Sep 2022
Publisher
Public Library of Science
e-ISSN
19326203
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2714023031
Copyright
© 2022 Castrosanto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.